We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
RPL30 is not prognostic in Ovary Serous Cystadenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average pTPM
5079.2
Number of samples
349
Samples
Sample
Description
pTPM
TCGA-10-0937-01A
44 years, female, white, stage:Stage IIIC, dead, 608 days
24185.5
TCGA-24-1464-01A
70 years, female, white, stage:Stage IIIC, dead, 379 days
16654.4
TCGA-29-1696-01A
43 years, female, white, stage:Stage IIIC, dead, 1032 days
16000.4
TCGA-09-0367-01A
67 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days
14657.0
TCGA-23-1022-01A
67 years, female, white, stage:Stage IIIC, dead, 1511 days
12950.2
TCGA-61-1725-01A
40 years, female, white, stage:Stage IIIC, alive, 956 days
12913.5
TCGA-30-1853-01A
58 years, female, white, stage:Stage IIIC, dead, 1103 days
12466.3
TCGA-59-2355-01A
58 years, female, white, stage:Stage IV, dead, 65 days
11657.1
TCGA-10-0938-01A
80 years, female, white, stage:Stage IIIC, dead, 636 days
10848.3
TCGA-04-1542-01A
52 years, female, white, stage:Stage IIIB, dead, 2561 days
10786.7
TCGA-13-0725-01A
44 years, female, white, stage:Stage IIIC, dead, 377 days
10293.2
TCGA-10-0927-01A
65 years, female, stage:Stage IIIC, dead, 2490 days
10291.9
TCGA-20-0987-01A
61 years, female, white, stage:Stage IIIC, dead, 701 days
10193.6
TCGA-30-1892-01A
52 years, female, white, stage:Stage IIIC, dead, 1484 days
10119.9
TCGA-24-0979-01A
53 years, female, white, stage:Stage IV, dead, 1264 days
10040.5
TCGA-13-1404-01A
48 years, female, white, stage:Stage IIIC, alive, 2469 days
9889.4
TCGA-29-1776-01A
63 years, female, black or african american, stage:Stage IIIC, alive, 360 days
9820.2
TCGA-13-1489-01A
70 years, female, white, stage:Stage IIIC, dead, 2553 days
9569.4
TCGA-24-2033-01A
87 years, female, white, stage:Stage IIIC, dead, 562 days
9358.1
TCGA-13-0924-01A
45 years, female, white, stage:Stage IV, alive, 2614 days
9075.7
TCGA-30-1714-01A
68 years, female, white, stage:Stage IV, dead, 1158 days
8992.0
TCGA-13-1409-01A
73 years, female, white, stage:Stage IIIC, dead, 1742 days
8973.7
TCGA-04-1350-01A
46 years, female, white, stage:Stage IIIC, dead, 1946 days
8892.1
TCGA-36-1569-01A
52 years, female, white, stage:Stage IIIC, alive, 885 days
8797.9
TCGA-29-2425-01A
60 years, female, white, stage:Stage IIIC, alive, 1977 days
8696.4
TCGA-29-1768-01A
50 years, female, white, stage:Stage IV, dead, 952 days
8643.6
TCGA-20-1687-01A
46 years, female, white, stage:Stage IV, alive, 81 days
8546.6
TCGA-57-1584-01A
47 years, female, white, stage:Stage IIIC, alive, 643 days
8488.5
TCGA-61-1907-01A
63 years, female, white, stage:Stage IIIC, alive, 952 days
8408.3
TCGA-13-1501-01A
50 years, female, white, stage:Stage IV, dead, 1314 days
8169.7
TCGA-13-1483-01A
61 years, female, white, stage:Stage IIIC, dead, 895 days
8159.4
TCGA-29-1703-01A
56 years, female, black or african american, stage:Stage IIIC, dead, 1815 days
7829.4
TCGA-24-0966-01A
78 years, female, black or african american, stage:Stage IIIC, alive, 232 days
7745.0
TCGA-09-1670-01A
57 years, female, white, stage:Stage IIIA, alive, 547 days
7692.6
TCGA-23-1113-01A
48 years, female, white, stage:Stage IV, dead, 949 days
7692.1
TCGA-31-1946-01A
30 years, female, stage:Stage IIIC, alive, 918 days
7683.0
TCGA-36-1570-01A
49 years, female, white, stage:Stage IIIC, alive, 655 days
7675.1
TCGA-13-1403-01A
48 years, female, white, stage:Stage IIIC, dead, 2345 days
7594.8
TCGA-13-1487-01A
74 years, female, white, stage:Stage IV, dead, 681 days
7568.7
TCGA-24-1553-01A
53 years, female, white, stage:Stage IIIB, dead, 1767 days
7545.2
TCGA-29-1690-01A
66 years, female, white, stage:Stage IIIC, dead, 1448 days
7510.2
TCGA-23-1116-01A
83 years, female, white, stage:Stage IIIC, dead, 592 days
7500.4
TCGA-13-0897-01A
54 years, female, white, stage:Stage IIIC, dead, 2182 days
7453.8
TCGA-10-0931-01A
44 years, female, white, stage:Stage IIIC, dead, 1000 days
7440.2
TCGA-36-1574-01A
48 years, female, asian, stage:Stage IIIC, alive, 686 days
7424.1
TCGA-23-1023-01A
65 years, female, white, stage:Stage IIIC, alive, 1233 days
7418.7
TCGA-23-1028-01A
43 years, female, white, stage:Stage IIIC, alive, 1503 days
7302.2
TCGA-29-1705-01A
47 years, female, white, stage:Stage IIIC, dead, 555 days
7259.5
TCGA-04-1361-01A
57 years, female, white, stage:Stage IIIB, alive, 989 days
7255.2
TCGA-24-0982-01A
77 years, female, white, stage:Stage IIIC, dead, 679 days
7254.6
TCGA-13-0724-01A
72 years, female, white, stage:Stage IV, dead, 83 days
7232.5
TCGA-25-1317-01A
66 years, female, white, stage:Stage IIIC, dead, 61 days
7174.8
TCGA-61-1721-01A
38 years, female, white, stage:Stage IV, alive, 338 days
7089.8
TCGA-24-1413-01A
51 years, female, white, stage:Stage IIIC, alive, 192 days
7033.4
TCGA-24-2298-01A
55 years, female, white, stage:Stage IIIC, dead, 1620 days
7019.7
TCGA-23-1109-01A
62 years, female, white, stage:Stage IIIC, dead, 1562 days
6975.2
TCGA-25-1316-01A
55 years, female, white, stage:Stage IIIC, dead, 1279 days
6939.5
TCGA-04-1338-01A
78 years, female, white, stage:Stage IIIC, alive, 1418 days
6920.9
TCGA-13-0765-01A
50 years, female, white, stage:Stage IIIC, dead, 1389 days
6900.9
TCGA-23-1119-01A
64 years, female, white, stage:Stage IIIC, alive, 3953 days
6874.9
TCGA-24-2038-01A
68 years, female, white, stage:Stage IIIA, dead, 1354 days
6822.4
TCGA-04-1341-01A
85 years, female, white, stage:'--, alive, 33 days
6791.0
TCGA-VG-A8LO-01A
55 years, female, black or african american, stage:Stage IV, dead, 24 days
6790.4
TCGA-24-1846-01A
45 years, female, stage:Stage IIIC, alive, 133 days
6766.5
TCGA-24-1105-01A
36 years, female, white, stage:Stage IIIC, dead, 1442 days
6760.6
TCGA-25-1329-01A
76 years, female, white, stage:Stage IIIC, dead, 457 days
6730.2
TCGA-36-1571-01A
53 years, female, white, stage:Stage IIIB, dead, 695 days
6730.1
TCGA-24-2023-01A
54 years, female, white, stage:Stage IIIA, dead, 1364 days
6663.2
TCGA-61-1919-01A
58 years, female, white, stage:Stage IIIC, dead, 1161 days
6654.8
TCGA-13-1512-01A
49 years, female, white, stage:Stage IIIC, alive, 442 days
6652.1
TCGA-24-1923-01A
51 years, female, white, stage:Stage IIIC, dead, 690 days
6634.3
TCGA-20-0991-01A
78 years, female, white, stage:Stage IIB, alive, 797 days
6584.4
TCGA-29-1693-01A
72 years, female, white, stage:Stage IIIC, alive, 3096 days
6573.7
TCGA-24-1435-01A
57 years, female, white, stage:Stage IIIC, dead, 1324 days
6373.2
TCGA-13-0720-01A
48 years, female, white, stage:Stage IIIC, dead, 1355 days
6360.1
TCGA-61-1737-01A
42 years, female, white, stage:Stage IV, alive, 1364 days
6356.5
TCGA-24-1467-01A
51 years, female, white, stage:Stage IIIC, dead, 3224 days
6352.4
TCGA-25-1634-01A
75 years, female, white, stage:Stage IIIC, dead, 1091 days
6328.2
TCGA-29-1761-01A
80 years, female, asian, stage:Stage IIIC, dead, 528 days
6297.6
TCGA-04-1343-01A
72 years, female, white, stage:Stage IV, dead, 361 days
6293.9
TCGA-13-0726-01A
55 years, female, white, stage:Stage IIIC, dead, 949 days
6259.0
TCGA-29-2414-01A
75 years, female, white, stage:Stage IIIC, dead, 2621 days
6257.8
TCGA-29-1784-01A
55 years, female, white, stage:Stage IIIC, alive, 163 days
6251.9
TCGA-29-1694-01A
45 years, female, white, stage:Stage IIIC, dead, 1187 days
6179.6
TCGA-61-1728-01A
59 years, female, white, stage:Stage IV, alive, 848 days
6156.7
TCGA-OY-A56Q-01A
78 years, female, black or african american, stage:Stage IIA, alive, 576 days
6149.7
TCGA-25-2401-01A
64 years, female, white, stage:Stage IIIC, dead, 90 days
6141.8
TCGA-13-0923-01A
74 years, female, white, stage:Stage IIIC, alive, 2547 days
6126.3
TCGA-61-2000-01A
67 years, female, white, stage:Stage IIIC, alive, 441 days
6069.6
TCGA-25-1632-01A
68 years, female, white, stage:Stage IV, dead, 1799 days
6038.1
TCGA-23-2078-01A
66 years, female, white, stage:Stage IIIC, alive, 2661 days
6031.0
TCGA-30-1891-01A
61 years, female, white, stage:Stage IIIC, dead, 914 days
5999.3
TCGA-09-1662-01A
58 years, female, white, stage:Stage IV, dead, 2717 days
5968.6
TCGA-13-0766-01A
42 years, female, white, stage:Stage IIIC, dead, 1725 days
5963.6
TCGA-24-1419-01A
62 years, female, white, stage:Stage IIIC, alive, 239 days
5942.9
TCGA-29-1766-01A
74 years, female, white, stage:Stage IIIC, dead, 1199 days
5941.4
TCGA-24-1563-01A
66 years, female, black or african american, stage:Stage IIIC, dead, 1451 days
5908.1
TCGA-04-1364-01A
61 years, female, white, stage:Stage IIIC, dead, 1024 days
5893.2
TCGA-61-1914-01A
65 years, female, stage:Stage IIIC, alive, 1722 days
5882.9
TCGA-31-1944-01A
47 years, female, white, stage:Stage IIIC, alive, 1386 days
5851.2
TCGA-23-2084-01A
45 years, female, white, stage:Stage IV, dead, 1516 days
5845.6
TCGA-24-1552-01A
77 years, female, white, stage:Stage IIIC, dead, 1259 days
5828.5
TCGA-61-2008-01A
40 years, female, asian, stage:Stage IIC, alive, 932 days
5820.4
TCGA-24-1427-01A
58 years, female, stage:Stage IIIC, alive, 147 days
5786.6
TCGA-09-0364-01A
80 years, female, white, stage:Stage IIC, dead, 887 days
5782.9
TCGA-25-2404-01A
38 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days
5770.1
TCGA-13-0885-01A
70 years, female, white, stage:Stage IIIC, alive, 3388 days
5761.6
TCGA-24-1471-01A
60 years, female, white, stage:Stage IIIC, alive, 36 days
5748.4
TCGA-23-1027-01A
48 years, female, white, stage:Stage IIIC, dead, 976 days
5731.0
TCGA-61-1910-01A
56 years, female, white, stage:Stage IIC, alive, 1127 days
5720.9
TCGA-29-1777-01A
47 years, female, white, stage:Stage IIIC, alive, 374 days
5714.3
TCGA-36-1580-01A
82 years, female, stage:Stage IIIC, dead, 737 days
5689.2
TCGA-61-1724-01A
47 years, female, white, stage:Stage IIIC, dead, 637 days
5670.2
TCGA-25-1631-01A
73 years, female, white, stage:Stage IIIC, dead, 9 days
5598.7
TCGA-20-1686-01A
75 years, female, white, stage:Stage IIIC, alive, 89 days
5579.0
TCGA-13-1505-01A
63 years, female, white, stage:Stage IIIC, alive, 1998 days
5575.4
TCGA-13-2060-01A
51 years, female, white, stage:Stage IV, alive, 2369 days
5568.2
TCGA-13-1477-01A
49 years, female, white, stage:Stage IV, dead, 1662 days
5564.8
TCGA-04-1356-01A
62 years, female, white, stage:Stage IIC, dead, 1499 days
5564.1
TCGA-24-1565-01A
74 years, female, white, stage:Stage IIIC, dead, 312 days
5538.6
TCGA-29-1778-01A
77 years, female, white, stage:Stage IIIC, alive, 454 days
5529.3
TCGA-29-1769-01A
40 years, female, white, stage:Stage IIIC, alive, 699 days
5528.4
TCGA-13-1488-01A
59 years, female, white, stage:Stage IV, dead, 2154 days
5528.2
TCGA-59-2363-01A
40 years, female, asian, stage:Stage IIIA, alive, 165 days
5491.7
TCGA-25-1313-01A
62 years, female, white, stage:Stage IV, dead, 820 days
5457.2
TCGA-23-1118-01A
45 years, female, white, stage:Stage IIIC, alive, 2616 days
5449.4
TCGA-61-2002-01A
46 years, female, white, stage:Stage IIIC, alive, 547 days
5449.2
TCGA-13-1499-01A
56 years, female, white, stage:Stage IIIC, alive, 3500 days
5325.0
TCGA-10-0928-01A
71 years, female, white, stage:Stage IIIC, dead, 563 days
5303.2
TCGA-25-2392-01A
75 years, female, white, stage:Stage IV, dead, 31 days
5296.0
TCGA-29-1783-01A
58 years, female, white, stage:Stage IIIC, alive, 220 days
5287.6
TCGA-30-1718-01A
44 years, female, white, stage:Stage IIIC, dead, 1579 days
5273.2
TCGA-23-1030-01A
64 years, female, white, stage:Stage IIIC, alive, 886 days
5253.2
TCGA-24-1562-01A
67 years, female, white, stage:Stage IIIC, dead, 1384 days
5227.8
TCGA-24-2024-01A
72 years, female, black or african american, stage:Stage IIIC, dead, 1769 days
5208.4
TCGA-24-1546-01A
46 years, female, white, stage:Stage IIIC, dead, 1955 days
5189.2
TCGA-24-1416-01A
34 years, female, white, stage:Stage IV, alive, 194 days
5187.8
TCGA-61-1998-01A
48 years, female, white, stage:Stage IIIC, alive, 168 days
5182.1
TCGA-29-2427-01A
60 years, female, white, stage:Stage IIIC, alive, 1900 days
5177.7
TCGA-24-1103-01A
50 years, female, black or african american, stage:Stage IIIC, dead, 1646 days
5177.2
TCGA-25-1328-01A
38 years, female, white, stage:Stage IIIC, dead, 2009 days
5177.0
TCGA-04-1362-01A
59 years, female, white, stage:Stage IIC, dead, 1348 days
5153.0
TCGA-23-1107-01A
59 years, female, white, stage:Stage IV, dead, 9 days
5141.3
TCGA-25-2409-01A
71 years, female, white, stage:Stage IV, dead, 821 days
5133.2
TCGA-13-1495-01A
60 years, female, white, stage:Stage IIIC, dead, 2749 days
5118.4
TCGA-31-1956-01A
60 years, female, white, stage:Stage IIIB, alive, 1342 days
5075.5
TCGA-13-1498-01A
73 years, female, white, stage:Stage IIIC, dead, 2012 days
5057.7
TCGA-29-1688-01A
39 years, female, white, stage:Stage IIIC, dead, 2400 days
5056.6
TCGA-61-2109-01A
40 years, female, white, stage:Stage IIIC, dead, 629 days
5036.9
TCGA-24-1418-01A
68 years, female, white, stage:Stage IIIC, alive, 243 days
5022.8
TCGA-25-2393-01A
81 years, female, white, stage:Stage IIIC, dead, 1157 days
5000.7
TCGA-24-1924-01A
65 years, female, white, stage:Stage IIIC, dead, 919 days
4984.0
TCGA-24-1431-01A
67 years, female, white, stage:Stage IIIC, dead, 583 days
4938.4
TCGA-23-1111-01A
63 years, female, white, stage:Stage IIIC, alive, 98 days
4932.3
TCGA-09-1666-01A
57 years, female, white, stage:Stage IIIC, alive, 1752 days
4927.1
TCGA-09-1669-01A
54 years, female, white, stage:Stage IIIA, alive, 928 days
4923.8
TCGA-29-1770-01A
54 years, female, white, stage:Stage IIIC, alive, 741 days
4909.3
TCGA-30-1861-01A
74 years, female, white, stage:Stage IIIC, dead, 1058 days
4909.3
TCGA-59-2354-01A
63 years, female, white, stage:Stage IIIC, dead, 1046 days
4893.1
TCGA-13-A5FT-01A
67 years, female, black or african american, stage:Stage IIIC, alive, 2143 days
4885.9
TCGA-57-1586-01A
66 years, female, white, stage:Stage IIIC, alive, 679 days
4869.4
TCGA-04-1519-01A
48 years, female, stage:Stage IIIC, alive, 24 days
4859.7
TCGA-29-1785-01A
55 years, female, white, stage:Stage IIIC, dead, 1104 days
4850.7
TCGA-25-1315-01A
50 years, female, white, stage:Stage IIIC, dead, 1583 days
4837.2
TCGA-30-1857-01A
64 years, female, white, stage:Stage IV, dead, 8 days
4818.7
TCGA-13-0727-01A
71 years, female, white, stage:Stage IIIC, dead, 462 days
4768.4
TCGA-59-A5PD-01A
55 years, female, black or african american, stage:Stage IC, dead, 624 days
4766.6
TCGA-09-1673-01A
50 years, female, white, stage:Stage IV, alive, 92 days
4717.8
TCGA-24-2020-01A
67 years, female, white, stage:Stage IIIC, dead, 4624 days
4675.2
TCGA-30-1862-01A
65 years, female, white, stage:Stage IV, dead, 186 days
4668.1
TCGA-13-0891-01A
73 years, female, white, stage:Stage IV, dead, 3128 days
4645.3
TCGA-24-1425-01A
45 years, female, white, stage:Stage IIIC, alive, 181 days
4641.9
TCGA-13-1485-01A
48 years, female, white, stage:Stage IV, dead, 629 days
4634.6
TCGA-24-2290-01A
56 years, female, white, stage:Stage IIIC, dead, 1102 days
4627.1
TCGA-13-0906-01A
50 years, female, white, stage:Stage IIIC, alive, 3619 days
4626.9
TCGA-04-1365-01A
87 years, female, white, stage:Stage IIIB, alive, 947 days
4618.2
TCGA-04-1332-01A
70 years, female, white, stage:Stage IIIC, dead, 1247 days
4616.6
TCGA-13-1506-01A
45 years, female, white, stage:Stage IIIC, dead, 1039 days
4597.1
TCGA-57-1583-01A
57 years, female, black or african american, stage:Stage IIIC, dead, 346 days
4585.7
TCGA-57-1582-01A
50 years, female, white, stage:Stage IIIC, dead, 731 days
4581.6
TCGA-25-1312-01A
69 years, female, white, stage:Stage IV, dead, 31 days
4572.5
TCGA-24-1604-01A
66 years, female, white, stage:Stage IIIC, dead, 2688 days
4547.7
TCGA-13-1408-01A
59 years, female, white, stage:Stage IIIC, dead, 1680 days
4534.5
TCGA-13-1507-01A
77 years, female, white, stage:Stage IIIC, dead, 1993 days
4523.5
TCGA-13-0714-01A
55 years, female, white, stage:Stage IV, dead, 189 days
4507.7
TCGA-23-1120-01A
60 years, female, white, stage:Stage IIIC, alive, 130 days
4473.8
TCGA-23-1024-01A
52 years, female, white, stage:Stage IV, alive, 468 days
4467.5
TCGA-24-1616-01A
56 years, female, white, stage:Stage IIIC, dead, 1163 days
4461.3
TCGA-13-0804-01A
73 years, female, white, stage:Stage IIIC, dead, 1073 days
4457.7
TCGA-20-1682-01A
56 years, female, white, stage:Stage IIIC, alive, 837 days
4399.6
TCGA-13-0886-01A
67 years, female, white, stage:Stage IIIC, alive, 4665 days
4397.3
TCGA-04-1536-01A
60 years, female, black or african american, stage:Stage IV, dead, 885 days
4388.7
TCGA-24-1842-01A
49 years, female, white, stage:Stage IIIC, alive, 253 days
4388.5
TCGA-25-2396-01A
71 years, female, white, stage:Stage IIIC, dead, 92 days
4364.3
TCGA-24-1567-01A
54 years, female, white, stage:Stage IIIB, dead, 524 days
4351.1
TCGA-24-1428-01A
50 years, female, white, stage:Stage IIIC, alive, 529 days
4332.2
TCGA-13-0795-01A
66 years, female, white, stage:Stage IIIC, dead, 619 days
4329.3
TCGA-5X-AA5U-01A
61 years, female, black or african american, stage:Stage IIC, alive, 361 days
4307.6
TCGA-61-1918-01A
45 years, female, white, stage:Stage IV, dead, 479 days
4249.7
TCGA-24-1430-01A
68 years, female, white, stage:Stage IIIC, dead, 863 days
4233.4
TCGA-04-1655-01A
49 years, female, white, stage:Stage IIIB, dead, 1380 days
4232.1
TCGA-24-0968-01A
59 years, female, white, stage:Stage IIIC, dead, 598 days
4212.8
TCGA-13-1509-01A
64 years, female, white, stage:Stage IV, alive, 2438 days
4188.5
TCGA-61-2101-01A
55 years, female, white, stage:Stage IIIC, dead, 1688 days
4183.6
TCGA-24-1844-01A
64 years, female, white, stage:Stage IIIC, alive, 113 days
4170.9
TCGA-24-1422-01A
82 years, female, black or african american, stage:Stage IIIC, dead, 23 days
4165.3
TCGA-23-1110-01A
42 years, female, white, stage:Stage IIIC, alive, 1658 days
4159.8
TCGA-13-1410-01A
57 years, female, white, stage:Stage IV, alive, 2464 days
4158.0
TCGA-36-1577-01A
43 years, female, asian, stage:Stage IIC, alive, 783 days
4153.6
TCGA-25-1326-01A
61 years, female, white, stage:Stage IIIC, dead, 1249 days
4147.9
TCGA-24-1417-01A
54 years, female, white, stage:Stage IV, alive, 238 days
4138.6
TCGA-61-1995-01A
43 years, female, white, stage:Stage IIIC, alive, 61 days
4135.2
TCGA-59-2351-01A
51 years, female, white, stage:Stage IIIC, alive, 3532 days
4128.9
TCGA-29-1781-01A
69 years, female, white, stage:Stage IIIC, alive, 255 days
4099.9
TCGA-24-2271-01A
55 years, female, asian, stage:Stage IIIC, dead, 962 days
4098.8
TCGA-24-2281-01A
68 years, female, white, stage:Stage IIA, alive, 1357 days
4095.2
TCGA-13-1496-01A
65 years, female, white, stage:Stage IIIC, dead, 129 days
4086.7
TCGA-24-1560-01A
51 years, female, white, stage:Stage IIIC, dead, 1341 days
4084.3
TCGA-25-1635-01A
71 years, female, white, stage:Stage IIIC, dead, 1583 days
4080.6
TCGA-57-1585-01A
57 years, female, white, stage:Stage IIIC, dead, 53 days
4073.9
TCGA-24-2297-01A
56 years, female, white, stage:Stage IIIC, dead, 1699 days
4051.3
TCGA-59-2350-01A
44 years, female, stage:Stage IV, dead, 679 days
4031.9
TCGA-09-2051-01A
42 years, female, white, stage:Stage IIIC, alive, 1919 days
4014.3
TCGA-13-0883-01A
61 years, female, white, stage:Stage IIIC, dead, 2097 days
4011.5
TCGA-25-1633-01A
64 years, female, white, stage:Stage IIIC, dead, 1891 days
4008.1
TCGA-25-2399-01A
80 years, female, white, stage:Stage IIIC, dead, 608 days
3999.3
TCGA-25-1318-01A
54 years, female, white, stage:Stage IIIC, dead, 1064 days
3973.0
TCGA-24-1847-01A
45 years, female, white, stage:Stage IV, alive, 343 days
3949.3
TCGA-24-1550-01A
49 years, female, white, stage:Stage IIIC, dead, 1249 days
3916.3
TCGA-13-0888-01A
78 years, female, white, stage:Stage IIIC, dead, 2811 days
3905.9
TCGA-24-1426-01A
43 years, female, white, stage:Stage IIIC, alive, 163 days
3897.5
TCGA-13-0800-01A
52 years, female, white, stage:Stage IIIC, alive, 2661 days
3889.7
TCGA-29-1695-01A
62 years, female, white, stage:Stage IIIC, dead, 1229 days
3876.9
TCGA-24-1558-01A
73 years, female, white, stage:Stage IIIC, dead, 594 days
3875.3
TCGA-25-1877-01A
81 years, female, white, stage:Stage IIIC, dead, 730 days
3870.6
TCGA-13-0911-01A
55 years, female, white, stage:Stage IV, dead, 1355 days
3858.7
TCGA-25-1870-01A
59 years, female, white, stage:Stage IIIC, dead, 455 days
3844.8
TCGA-24-1434-01A
59 years, female, white, stage:Stage IIIC, dead, 568 days
3804.9
TCGA-25-1630-01A
73 years, female, white, stage:Stage IIIC, dead, 1162 days
3793.7
TCGA-24-1603-01A
53 years, female, white, stage:Stage IIIB, dead, 2742 days
3775.4
TCGA-61-2092-01A
57 years, female, white, stage:Stage IIIC, alive, 1573 days
3683.8
TCGA-13-1407-01A
51 years, female, white, stage:Stage IIIC, alive, 2534 days
3667.0
TCGA-24-2254-01A
66 years, female, white, stage:Stage IIIC, dead, 1736 days
3663.3
TCGA-36-1568-01A
52 years, female, stage:Stage IIIC, alive, 875 days
3662.5
TCGA-24-1474-01A
57 years, female, black or african american, stage:Stage IIIC, dead, 676 days
3653.8
TCGA-25-2400-01A
76 years, female, white, stage:Stage IIIC, dead, 1278 days
3645.1
TCGA-25-1627-01A
73 years, female, white, stage:Stage IIIC, dead, 394 days
3642.3
TCGA-13-1511-01A
52 years, female, asian, stage:Stage IV, dead, 1650 days
3625.3
TCGA-23-1123-01A
59 years, female, white, stage:Stage IIIC, dead, 1018 days
3617.5
TCGA-61-2097-01A
71 years, female, white, stage:Stage IIC, alive, 1844 days
3616.0
TCGA-04-1651-01A
53 years, female, white, stage:Stage IIIC, dead, 1102 days
3608.3
TCGA-09-2048-01A
63 years, female, white, stage:Stage IIIC, dead, 138 days
3590.2
TCGA-36-1576-01A
76 years, female, stage:Stage IIIC, alive, 915 days
3580.5
TCGA-04-1347-01A
81 years, female, white, stage:Stage IV, alive, 1919 days
3575.5
TCGA-61-2110-01A
56 years, female, white, stage:Stage IIIC, dead, 1354 days
3571.1
TCGA-61-1911-01A
55 years, female, white, stage:Stage IIA, alive, 1293 days
3570.5
TCGA-13-1510-01A
62 years, female, white, stage:Stage IIIC, dead, 1359 days
3559.0
TCGA-20-1683-01A
65 years, female, white, stage:Stage IIIC, alive, 772 days
3559.0
TCGA-13-0797-01A
49 years, female, white, stage:Stage IIIC, alive, 2121 days
3558.7
TCGA-25-1628-01A
67 years, female, white, stage:Stage IIIC, dead, 627 days
3532.8
TCGA-24-1104-01A
56 years, female, white, stage:Stage IV, dead, 1933 days
3531.2
TCGA-24-1544-01A
71 years, female, black or african american, stage:Stage IIIC, dead, 820 days
3473.7
TCGA-25-1320-01A
65 years, female, white, stage:Stage IIIC, dead, 1155 days
3415.4
TCGA-31-1951-01A
58 years, female, white, stage:Stage IIIC, alive, 684 days
3412.0
TCGA-24-2035-01A
65 years, female, white, stage:Stage IIIC, dead, 857 days
3380.4
TCGA-24-1557-01A
49 years, female, white, stage:Stage IIIC, dead, 1213 days
3248.4
TCGA-30-1866-01A
61 years, female, white, stage:Stage IV, dead, 1114 days
3243.6
TCGA-25-1321-01A
65 years, female, white, stage:Stage IIIC, dead, 1033 days
3240.6
TCGA-25-2398-01A
71 years, female, white, stage:Stage IIIC, dead, 1369 days
3232.6
TCGA-13-1411-01A
81 years, female, white, stage:Stage IIIC, dead, 531 days
3232.2
TCGA-29-2428-01A
58 years, female, white, stage:Stage IIIC, alive, 1372 days
3229.2
TCGA-25-1323-01A
72 years, female, white, stage:Stage IIIC, dead, 395 days
3209.5
TCGA-04-1514-01A
45 years, female, white, stage:Stage IIIA, dead, 1720 days
3204.2
TCGA-13-0730-01A
71 years, female, white, stage:Stage IIIC, dead, 542 days
3198.5
TCGA-24-2261-01A
76 years, female, white, stage:Stage IIIC, dead, 24 days
3198.4
TCGA-61-2009-01A
65 years, female, white, stage:Stage IIIC, alive, 1212 days
3179.3
TCGA-24-2027-01A
51 years, female, white, stage:Stage IV, dead, 3337 days
3159.0
TCGA-13-1497-01A
47 years, female, white, stage:Stage IIIC, alive, 3871 days
3158.5
TCGA-61-2111-01A
61 years, female, white, stage:Stage IV, alive, 3825 days
3138.7
TCGA-29-1701-01A
56 years, female, white, stage:Stage IIIC, dead, 515 days
3131.3
TCGA-25-1623-01A
71 years, female, white, stage:Stage IV, dead, 565 days
3105.0
TCGA-61-1741-01A
76 years, female, white, stage:Stage IIIB, dead, 1024 days
3090.7
TCGA-13-0762-01A
65 years, female, white, stage:Stage IIIC, alive, 3400 days
3073.2
TCGA-61-1738-01A
60 years, female, black or african american, stage:Stage IIIC, dead, 1089 days
3060.7
TCGA-24-2026-01A
79 years, female, white, stage:Stage IIIC, dead, 1059 days
3039.1
TCGA-24-1549-01A
58 years, female, white, stage:Stage IIIB, dead, 1721 days
2967.9
TCGA-29-1697-01A
62 years, female, white, stage:Stage IIIC, dead, 949 days
2913.7
TCGA-29-A5NZ-01A
66 years, female, black or african american, stage:Stage IIIC, dead, 1088 days
2893.2
TCGA-13-0768-01A
73 years, female, white, stage:Stage IIIC, dead, 1784 days
2878.3
TCGA-24-2267-01A
58 years, female, white, stage:Stage IIB, dead, 1446 days
2876.5
TCGA-30-1860-01A
58 years, female, white, stage:Stage IIIC, dead, 1366 days
2868.1
TCGA-13-1492-01A
66 years, female, white, stage:Stage IIIC, dead, 3819 days
2866.2
TCGA-24-1551-01A
53 years, female, white, stage:Stage IIIC, dead, 1579 days
2863.8
TCGA-10-0933-01A
77 years, female, white, stage:Stage IIIC, dead, 446 days
2817.4
TCGA-04-1331-01A
78 years, female, white, stage:Stage IIIC, dead, 1336 days
2789.9
TCGA-24-1845-01A
42 years, female, white, stage:Stage IIIC, alive, 116 days
2784.3
TCGA-13-0887-01A
42 years, female, white, stage:Stage IIIC, dead, 2028 days
2772.8
TCGA-25-1322-01A
62 years, female, white, stage:Stage IV, dead, 91 days
2738.6
TCGA-09-0369-01A
56 years, female, white, stage:Stage IIIC, dead, 1082 days
2703.4
TCGA-24-1843-01A
66 years, female, white, stage:Stage IIIC, alive, 106 days
2677.8
TCGA-61-1733-01A
71 years, female, white, stage:Stage IIIC, alive, 967 days
2672.8
TCGA-61-2098-01A
62 years, female, white, stage:Stage IIIC, alive, 1993 days
2661.5
TCGA-04-1530-01A
68 years, female, white, stage:Stage IIIC, dead, 3622 days
2656.0
TCGA-59-2348-01A
59 years, female, white, stage:Stage IIIC, alive, 5481 days
2645.8
TCGA-WR-A838-01A
72 years, female, black or african american, stage:Stage IIIC, dead, 304 days
2643.3
TCGA-61-2088-01A
51 years, female, white, stage:Stage IIIC, alive, 145 days
2635.9
TCGA-13-1405-01A
49 years, female, white, stage:Stage IV, dead, 868 days
2604.1
TCGA-24-1930-01A
53 years, female, white, stage:Stage IIIC, dead, 2467 days
2582.7
TCGA-13-0920-01A
65 years, female, white, stage:Stage IIIC, dead, 1484 days
2574.9
TCGA-25-2042-01A
60 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days
2574.8
TCGA-04-1648-01A
57 years, female, white, stage:Stage IIIC, dead, 871 days
2567.7
TCGA-31-1953-01A
52 years, female, asian, stage:Stage IIIC, alive, 204 days
2559.8
TCGA-23-1122-01A
53 years, female, white, stage:Stage IIIC, dead, 1189 days
2558.1
TCGA-61-2003-01A
53 years, female, white, stage:Stage IIIC, alive, 122 days
2533.7
TCGA-24-1423-01A
61 years, female, white, stage:Stage IIIC, alive, 190 days
2515.8
TCGA-24-2289-01A
68 years, female, white, stage:Stage IV, dead, 2049 days
2505.5
TCGA-29-1774-01A
82 years, female, white, stage:Stage IIIC, alive, 527 days
2477.8
TCGA-31-1959-01A
49 years, female, white, stage:Stage IV, alive, 67 days
2473.1
TCGA-09-2054-01A
58 years, female, black or african american, stage:Stage IIIC, dead, 637 days
2445.9
TCGA-57-1994-01A
63 years, female, white, stage:'--, alive, 761 days
2426.6
TCGA-09-2045-01A
50 years, female, asian, stage:Stage IV, dead, 1069 days
2425.5
TCGA-24-1928-01A
77 years, female, white, stage:Stage IIIC, dead, 336 days
2382.8
TCGA-57-1993-01A
56 years, female, white, stage:Stage IIIC, alive, 763 days
2374.2
TCGA-29-1691-01A
51 years, female, white, stage:Stage IIIC, dead, 1470 days
2366.1
TCGA-24-2036-01A
50 years, female, white, stage:Stage IIIA, dead, 1947 days
2355.0
TCGA-24-2280-01A
74 years, female, white, stage:Stage IIIC, alive, 2143 days
2353.8
TCGA-23-2077-01A
45 years, female, white, stage:Stage IIIC, alive, 3525 days
2329.9
TCGA-61-2113-01A
53 years, female, white, stage:Stage IIC, dead, 676 days
2321.1
TCGA-24-1424-01A
67 years, female, white, stage:Stage IIIC, alive, 183 days
2290.6
TCGA-59-2352-01A
78 years, female, white, stage:Stage IIIC, dead, 286 days
2290.5
TCGA-24-2293-01A
47 years, female, white, stage:'--, dead, 506 days
2281.3
TCGA-31-1950-01A
76 years, female, white, stage:Stage IIIC, alive, 571 days
2275.6
TCGA-09-0366-01A
55 years, female, white, stage:Stage IIIC, dead, 1757 days
2254.6
TCGA-61-2102-01A
74 years, female, white, stage:Stage IIIC, dead, 197 days
2253.2
TCGA-61-2104-01A
53 years, female, white, stage:Stage IIC, alive, 2338 days
2184.9
TCGA-29-1710-01A
54 years, female, white, stage:Stage IIIC, dead, 951 days
2116.3
TCGA-24-2288-01A
70 years, female, white, stage:Stage IIIC, dead, 25 days
2082.9
TCGA-23-1809-01A
63 years, female, white, stage:Stage IIC, alive, 16 days
2068.4
TCGA-25-1319-01A
73 years, female, white, stage:Stage IIIC, dead, 1977 days
1977.5
TCGA-29-1762-01A
59 years, female, white, stage:Stage IV, dead, 2634 days
1950.3
TCGA-25-1626-01A
65 years, female, white, stage:Stage IIIC, dead, 518 days
1947.3
TCGA-36-1581-01A
63 years, female, white, stage:Stage IIC, alive, 751 days
1845.3
TCGA-61-2012-01A
81 years, female, white, stage:Stage IIC, alive, 932 days
1817.0
TCGA-13-0916-01A
49 years, female, white, stage:Stage IIIC, alive, 1785 days
1801.3
TCGA-24-1469-01A
71 years, female, white, stage:Stage IIIC, alive, 277 days
1773.8
TCGA-61-1900-01A
51 years, female, black or african american, stage:Stage IIIB, alive, 176 days
1730.2
TCGA-24-1850-01A
72 years, female, white, stage:Stage IIIC, alive, 168 days
1677.3
TCGA-29-1711-01A
45 years, female, black or african american, stage:Stage IIIC, alive, 1053 days
1258.9
TCGA-29-1763-01A
43 years, female, black or african american, stage:Stage IIC, alive, 2032 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
RPL30 is not prognostic in Ovary Serous Cystadenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average pTPM
4324.0
Number of samples
81
Samples
Sample
Description
pTPM
DO46392
48 years, female, NA, stage:III, dead, 628 days
10346.8
DO46568
66 years, female, NA, stage:III, dead, 320 days
9187.4
DO46390
65 years, female, NA, stage:III, dead, 374 days
7947.6
DO46586
55 years, female, NA, stage:III, dead, 1019 days
7735.7
DO46342
67 years, female, NA, stage:III, dead, 1398 days
7531.3
DO46380
51 years, female, NA, stage:III, dead, 1423 days
7281.7
DO46356
68 years, female, NA, stage:III, dead, 911 days
7274.2
DO46333
58 years, female, NA, stage:III, dead, 359 days
7247.3
DO46331
72 years, female, NA, stage:III, dead, 612 days
7120.5
DO46518
62 years, female, NA, stage:III, alive, 2960 days
6982.0
DO46463
49 years, female, NA, stage:III, dead, 2451 days
6711.4
DO46551
58 years, female, NA, stage:III, dead, 1055 days
6681.7
DO46384
55 years, female, NA, stage:III, dead, 614 days
6503.3
DO46388
74 years, female, NA, stage:III, dead, 413 days
6469.7
DO46338
59 years, female, NA, stage:III, dead, 596 days
6283.2
DO46360
58 years, female, NA, stage:IV, dead, 1759 days
6229.7
DO46576
75 years, female, NA, stage:III, alive, 133 days
6207.7
DO46408
56 years, female, NA, stage:III, dead, 489 days
6141.7
DO46566
78 years, female, NA, stage:III, dead, 673 days
5850.9
DO46453
66 years, female, NA, stage:III, dead, 3294 days
5323.3
DO46386
49 years, female, NA, stage:III, dead, 1162 days
5177.5
DO46370
54 years, female, NA, stage:III, dead, 1727 days
5107.8
DO46334
77 years, female, NA, stage:III, dead, 496 days
5045.1
DO46366
65 years, female, NA, stage:III, dead, 2054 days
4856.4
DO46493
62 years, female, NA, stage:IV, alive, 839 days
4815.4
DO46400
70 years, female, NA, stage:III, dead, 719 days
4771.2
DO46325
54 years, female, NA, stage:III, dead, 477 days
4681.6
DO46513
54 years, female, NA, stage:IV, dead, 1883 days
4664.7
DO46398
66 years, female, NA, stage:III, alive, 437 days
4634.1
DO46344
46 years, female, NA, stage:III, dead, 642 days
4451.1
DO46402
77 years, female, NA, stage:III, dead, 511 days
4439.2
DO46354
73 years, female, NA, stage:III, dead, 843 days
4438.9
DO46443
59 years, female, NA, stage:III, dead, 2464 days
4399.2
DO46346
54 years, female, NA, stage:III, dead, 1187 days
4386.6
DO46340
62 years, female, NA, stage:III, dead, 616 days
4315.4
DO46372
39 years, female, NA, stage:III, dead, 1326 days
4301.4
DO46394
61 years, female, NA, stage:IV, dead, 1039 days
4294.1
DO46581
66 years, female, NA, stage:III, dead, 408 days
4232.5
DO46538
57 years, female, NA, stage:III, dead, 1527 days
4181.4
DO46591
58 years, female, NA, stage:III, dead, 195 days
4109.5
DO46611
52 years, female, NA, stage:III, dead, 734 days
4021.3
DO46404
55 years, female, NA, stage:III, dead, 690 days
4018.4
DO46597
60 years, female, NA, stage:III, dead, 393 days
3981.2
DO46523
52 years, female, NA, stage:IV, alive, 1873 days
3884.2
DO46533
46 years, female, NA, stage:III, alive, 3667 days
3841.2
DO46508
50 years, female, NA, stage:III, dead, 2101 days
3794.3
DO46326
51 years, female, NA, stage:III, dead, 701 days
3760.8
DO46364
45 years, female, NA, stage:III, dead, 806 days
3760.2
DO46528
56 years, female, NA, stage:III, alive, 6139 days
3632.5
DO46328
52 years, female, NA, stage:III, dead, 972 days
3462.9
DO46327
54 years, female, NA, stage:III, dead, 184 days
3247.8
DO46330
60 years, female, NA, stage:III, dead, 684 days
3245.5
DO46438
55 years, female, NA, stage:IV, alive, 2227 days
3242.5
DO46329
52 years, female, NA, stage:III, dead, 1699 days
3216.8
DO46374
69 years, female, NA, stage:III, dead, 1409 days
3187.7
DO46348
58 years, female, NA, stage:IV, dead, 287 days
3142.7
DO46352
60 years, female, NA, stage:III, dead, 677 days
3015.2
DO46546
73 years, female, NA, stage:III, dead, 1889 days
3005.5
DO46436
58 years, female, NA, stage:III, alive, 3193 days
2993.5
DO46378
59 years, female, NA, stage:III, alive, 843 days
2981.0
DO46448
45 years, female, NA, stage:III, dead, 654 days
2948.0
DO46362
61 years, female, NA, stage:III, dead, 1639 days
2708.8
DO46606
73 years, female, NA, stage:III, alive, 804 days
2694.6
DO46432
56 years, female, NA, stage:III, alive, 2218 days
2675.0
DO46571
61 years, female, NA, stage:III, dead, 243 days
2579.3
DO46560
45 years, female, NA, stage:IV, dead, 286 days
2566.0
DO46376
58 years, female, NA, stage:III, dead, 1430 days
2542.8
DO46412
64 years, female, NA, stage:III, dead, 597 days
2520.1
DO46396
64 years, female, NA, stage:III, dead, 583 days
2504.3
DO46332
56 years, female, NA, stage:III, dead, 689 days
2451.6
DO46588
74 years, female, NA, stage:III, dead, 438 days
2415.8
DO46358
60 years, female, NA, stage:III, dead, 423 days
2411.6
DO46561
52 years, female, NA, stage:III, dead, 195 days
2344.1
DO46602
74 years, female, NA, stage:III, dead, 205 days
2293.9
DO46368
57 years, female, NA, stage:III, dead, 2879 days
2123.1
DO46382
62 years, female, NA, stage:IV, dead, 311 days
1984.6
DO46458
67 years, female, NA, stage:IV, alive, 3787 days
1933.8
DO46336
70 years, female, NA, stage:IV, dead, 664 days
1911.0
DO46468
67 years, female, NA, stage:III, alive, 2776 days
1856.8
DO46350
66 years, female, NA, stage:III, dead, 886 days
1688.4
DO46428
59 years, female, NA, stage:IV, alive, 2644 days
1295.7
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
108
Samples
Sample ID
Sample type
nRPX
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2
Tumor
0.3
8d78194e-fbef-4819-a7b5-b73ae9_D2
Tumor
0.3
318d53c3-216b-4de1-a098-77d6dd_D2
Tumor
0.2
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2
Tumor
0.2
7069e990-4a4e-4984-a66d-4d835a_D2
Tumor
0.1
3e746bea-ed68-40e6-b348-6ddf08_D2
Normal
0.1
0cc794c3-5bf5-4621-b238-58a0f6_D2
Tumor
0.1
eb0a53df-7620-4024-8d2d-051142_D2
Tumor
0.1
fe83e13f-9754-403b-8f74-d6caf8_D2
Tumor
0.1
927f0958-db5a-4bc5-92b7-2a3695_D2
Tumor
0.1
91b287fd-eadb-442d-abcd-20b741_D2
Tumor
0.1
5c3971ee-87c7-4dff-b66e-f18892_D2
Tumor
0.1
2b4ce90c-8036-4207-ac3e-54a76f_D2
Tumor
0.1
9c8e78bf-b03e-4ba0-9909-5ff070_D2
Tumor
0.0
2115808b-6a0d-49bc-a8d7-b83bde_D2
Tumor
0.0
a03d1103-b809-42c4-ad5c-5aff58_D2
Tumor
0.0
80873a0c-1f40-4d51-bab1-3f2071_D2
Tumor
0.0
af95e2c6-25c4-4ab8-bf06-3e15ff_D2
Tumor
0.0
76e77c6b-c80e-4391-bdbb-e1dcea_D2
Tumor
0.0
41d0619e-b299-42e2-ac32-29e784_D2
Tumor
0.0
d109a3c0-350e-47f5-bda0-61899c_D2
Tumor
-0.1
627e6e36-3dca-4ee5-9755-6f3510_D2
Tumor
-0.1
161317f3-1a39-438e-af45-cd2502_D2
Tumor
-0.1
3fbf076a-824b-4eac-b6dc-bf5e59_D2
Normal
-0.1
a65d8e76-640f-4341-a561-afbb57_D2
Normal
-0.1
1c9145ad-1981-4871-aa7e-8b11de_D2
Tumor
-0.1
5ea22f5e-307b-491d-801f-8b7fa6_D2
Tumor
-0.1
7d953d1d-84b6-4ecd-b1d7-1ed865_D2
Tumor
-0.2
42d860a3-8a0c-4c44-a09a-9ad8cf_D2
Tumor
-0.2
1b2ab076-c72f-4bbe-b9f9-657d24_D2
Tumor
-0.2
3490835c-c004-45ed-91f3-7c206f_D2
Tumor
-0.2
05387aad-2a1f-42c2-8d6f-950598_D3
Tumor
-0.2
285fed94-1495-448e-879b-b55de9_D2
Tumor
-0.2
256ac9f5-1e19-44b4-92fb-fef3fc_D2
Tumor
-0.3
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2
Tumor
-0.3
2563cb02-d58a-4286-8634-7502cd_D2
Tumor
-0.3
50997c44-1c8b-4d34-b535-4a6cc2_D2
Tumor
-0.3
e9d416e7-f661-400a-896e-388545_D2
Tumor
-0.3
6530147a-efe9-4df6-ac2f-03ece3_D2
Tumor
-0.3
d4791079-c826-4fc7-9d9b-ee20ba_D2
Tumor
-0.3
1db5574d-aca7-403c-8100-6e705f_D2
Normal
-0.3
092af714-b97a-457c-b0e9-8c20e8_D2
Normal
-0.3
79b60f32-6cca-4cb6-9a1e-22a3ac_D2
Tumor
-0.3
08296da7-70ea-44df-8646-09f2cc_D2
Tumor
-0.3
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2
Tumor
-0.3
4ccb249a-6722-491e-97e9-e3b4e7_D2
Tumor
-0.3
31c15e30-21d4-4843-bd4a-9cd0d8_D2
Normal
-0.3
1556af7e-c2ae-4fce-9aae-87c459_D1_D2
Normal
-0.4
62f5840e-6cd7-4200-b651-645e53_D2
Tumor
-0.4
eb3f3494-7057-4afe-b212-e6e9a3_D2
Tumor
-0.4
9b90eb78-2f50-4aeb-b010-d642f9_D2
Tumor
-0.4
2224c03f-b7b1-4368-887e-2b4cdf_D2
Tumor
-0.4
3a380577-c134-47ba-a1ce-988d7c_D2
Tumor
-0.4
28d0abdb-f682-4bd3-9425-a9c508_D2
Tumor
-0.4
a3a26070-fb84-406a-8280-d555e6_D2
Normal
-0.4
340a3769-3031-41ae-bb08-a2f696_D2
Normal
-0.4
69d552be-7cb2-4bb4-b602-a27b3e_D2
Tumor
-0.5
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2
Tumor
-0.5
35a345a4-e954-4c81-ae3f-7797cd_D2
Tumor
-0.5
f6c215ea-5381-4521-bb61-be8e97_D2
Tumor
-0.5
e3ebe010-cd31-4b5d-8fcb-b7103b_D2
Tumor
-0.5
15524912-685a-47ce-a824-567848_D2
Tumor
-0.5
a8853382-b726-4ce8-98d5-ca89df_D2
Tumor
-0.5
b9c1f22e-61f7-45ed-b3b4-5094c7_D2
Normal
-0.6
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2
Tumor
-0.6
46c73531-f531-4ec3-97fe-b39d9d_D2
Tumor
-0.6
6319b36b-533c-4e86-8e12-80552e_D3
Tumor
-0.6
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3
Tumor
-0.6
6e209757-a7f4-45af-b5f3-2ebc02_D2
Normal
-0.6
2b73e01c-347a-4dae-a71d-752aeb_D2
Normal
-0.6
558333b0-ea23-4303-9e3c-4932b1_D2
Tumor
-0.6
9e0d47e0-f633-468b-b82b-4d752d_D2
Tumor
-0.6
d38f40fb-dd78-43b2-8b7b-4b6977_D2
Tumor
-0.7
a583d3ff-8165-43e9-b764-23b7ef_D1_D2
Normal
-0.7
e23eb014-69c1-460a-b9d4-9786c8_D2
Normal
-0.7
52c064a7-78d9-4a1a-85b4-27c6d1_D2
Tumor
-0.7
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2
Tumor
-0.7
2433b136-fc7b-4cea-b958-bc6efb_D2
Tumor
-0.7
21efd60f-6a31-4b98-9477-16a905_D2
Normal
-0.7
3d3e1888-d67e-4c69-ba83-112d0f_D2
Tumor
-0.8
1772e913-f62e-446a-8cf3-720348_D2
Tumor
-0.8
8e17b45e-6a06-4e4e-913d-7b1edb_D2
Tumor
-0.8
efc971f8-54c5-4531-a792-705ecf_D2
Tumor
-0.8
27f3ca2d-a86f-479d-8e7e-5307c7_D2
Tumor
-0.8
3946a96c-e0ae-442f-83b4-a9350e_D2
Tumor
-0.8
bd266bdd-12e4-42cb-9c49-911bfc_D2
Tumor
-0.9
994f9b8e-46cb-413f-8ec8-2c2fed_D2
Normal
-0.9
0c87932d-b6fd-4eb5-b86a-a34d07_D2
Tumor
-0.9
10c2d629-0287-4511-ac25-f29031_D2
Tumor
-0.9
e6850782-fd2a-4c53-b682-1852fe_D2
Tumor
-0.9
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2
Normal
-0.9
c17b0ff9-9057-4848-a0cc-abb25f_D2
Tumor
-0.9
347e379b-77c0-4dd3-aa25-18c9d1_D2
Tumor
-0.9
0745488e-0bfb-4d1f-8228-dedf76_D1_D2
Normal
-0.9
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2
Tumor
-0.9
61f76fe6-a1c6-41b8-bdc2-2f9209_D2
Normal
-1.0
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2
Normal
-1.0
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2
Tumor
-1.0
49bd51fe-48a1-4828-b66e-b30c38_D2
Tumor
-1.0
2f901c90-617e-46da-9fac-d68369_D2
Tumor
-1.0
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2
Tumor
-1.0
fbb41c94-aabd-49cc-90b2-882c3e_D2
Tumor
-1.0
1a10c200-3895-4648-b951-94f99f_D2
Tumor
-1.0
7edfd606-4bee-4529-9fec-1ca7f0_D2
Normal
-1.1
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2
Normal
-1.1
51a4ce2f-4166-4c6b-a7e0-942d0a_D2
Tumor
-1.1
b22659b9-e12c-4725-a7db-a833de_D1_D2
Normal
-1.1
2ed8beb2-bc63-4bad-b5fe-1916a0_D2
Tumor
-1.3
Show allShow less
OVARIAN CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.
The Human Protein Atlas project is funded
